Please use this identifier to cite or link to this item: https://hdl.handle.net/2440/119719
Full metadata record
DC FieldValueLanguage
dc.contributor.authorMorel, K.-
dc.contributor.authorOrmsby, R.-
dc.contributor.authorBezak, E.-
dc.contributor.authorTilley, W.-
dc.contributor.authorLawrence, M.-
dc.contributor.authorSykes, P.-
dc.date.issued2013-
dc.identifier.citationBJU International, 2013, vol.112, iss.Suppl. 1, pp.45-45-
dc.identifier.issn1464-4096-
dc.identifier.issn1464-410X-
dc.identifier.urihttp://hdl.handle.net/2440/119719-
dc.descriptionAbstract: Prostate Cancer World Congress & 14th Australasian Prostate Cancer Conference, Melbourne, Australia, 6–10 August 2013-
dc.description.statementofresponsibilityKatherine Morel, Rebecca Ormsby, Eva Bezak, Wayne Tilley, Mark Lawrence, and Pamela Sykes-
dc.language.isoen-
dc.publisherWiley-
dc.rights© 2013 The Authors BJU International © 2013 BJU International-
dc.titleParthenolide as a selective radiosensitiser in the treatment and prevention of prostate cancer-
dc.typeConference paper-
dc.contributor.conferenceProstate Cancer World Congress & Australasian Prostate Cancer Conference (6 Aug 2013 - 10 Aug 2013 : Melbourne)-
pubs.publication-statusPublished-
dc.identifier.orcidMorel, K. [0000-0002-7968-4032]-
dc.identifier.orcidBezak, E. [0000-0002-1315-1735]-
dc.identifier.orcidTilley, W. [0000-0003-1893-2626]-
Appears in Collections:Aurora harvest 8
Medicine publications

Files in This Item:
There are no files associated with this item.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.